AstraZeneca India Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

What the job involves

A Pharmacovigilance (PV) Analyst monitors the safety of medicines after they reach the market by collecting, assessing, and reporting adverse event (AE) information. Day to day, they triage individual case safety reports (ICSRs), code events using MedDRA, assess causality and seriousness, and prepare submissions to regulators within strict timelines. They also support signal detection, literature screening, and periodic safety reports while ensuring compliance with GVP and 21 CFR Part 312/314.

Role and Technical Knowledge

1. 1

   What is an ICSR and what are the four minimum criteria for a valid case?

   Define ICSR as a report of an adverse event after a medicine. List the four criteria: identifiable patient, identifiable reporter, suspect product, and adverse event. Mention that missing any one makes it invalid for reporting.

2. 2

   Explain the difference between an adverse event (AE), adverse drug reaction (ADR), and serious adverse event (SAE).

   AE is any untoward medical occurrence, ADR is a response to a drug that is noxious and unintended, and SAE results in death, hospitalization, disability, congenital anomaly, or is life-threatening. Use examples to show clarity.

3. 3

   What are the regulatory timelines for reporting a serious unexpected adverse reaction to a regulator?

   For post-marketing, serious unexpected ADRs are expedited within 15 calendar days; fatal or life-threatening cases within 7 calendar days for investigational drugs. Mention that timelines are from the date the company first receives the minimum criteria.

4. 4

   What is MedDRA and how is it used in pharmacovigilance?

   MedDRA is the Medical Dictionary for Regulatory Activities. It has a five-level hierarchy: LLT, PT, HLT, HLGT, SOC. Explain that PT is used for coding and analysis, and SOC for aggregate reporting.

Practical Scenarios

1. 5

   You receive a call from a patient who says they felt dizzy after taking a new medicine. What do you do?

   Show you would collect the four minimum criteria, ask about seriousness, timings, concomitant medications, and medical history. Explain you would document the call, enter it into the safety database, and route it for medical review within timelines.

2. 6

   A case report mentions 'patient had a heart attack' but does not state if it was fatal. How do you classify seriousness?

   State that 'heart attack' (myocardial infarction) is medically serious because it is life-threatening and may require hospitalization. You would mark it serious, follow up for outcome, and not downgrade without medical confirmation.

3. 7

   You notice a discrepancy between the narrative and the coded terms in a case. What steps do you take?

   Explain you would raise a query, verify the source document, correct the coding or narrative as needed, and document the change. Emphasize data integrity and following SOPs.

4. 8

   How would you handle a case where the reporter is anonymous but provides a suspect drug and event?

   State that without an identifiable reporter, it is not a valid ICSR for regulatory reporting. You would still record it in the database for signal review, but it would not be expedited. Mention you would not attempt to identify the reporter.

Behavioural and Situational

1. 9

   Tell me about a time you had to meet a tight deadline with multiple tasks.

   Use STAR format. Highlight prioritization, use of checklists, communication with team, and the outcome. Relate it to PV where timelines are critical.

2. 10

   Describe a situation where you made a mistake in documentation. How did you handle it?

   Show honesty, ownership, and corrective action. Mention you reported it immediately, corrected the record, and learned to double-check. Emphasize that in PV, transparency is essential.

3. 11

   How do you handle a disagreement with a senior about the seriousness of a case?

   Show respect and evidence-based discussion. Say you would present the case details, refer to guidelines, and escalate if needed. Highlight patient safety as the priority.

4. 12

   Why do you want to work in pharmacovigilance, and why this company?

   Connect your life sciences background to patient safety. Mention the company's global reach and compliance culture, and show you understand the role's impact. Avoid generic answers.

HR and Company Fit

1. 13

   What do you know about our company's pharmacovigilance operations?

   Research the company's therapy areas, global safety database, and regulatory footprint. Mention their commitment to patient safety and any public PV initiatives. Do not claim to know internal processes.

2. 14

   How do you ensure accuracy and attention to detail in repetitive tasks like data entry?

   Talk about using checklists, peer review, taking short breaks, and following SOPs. Give an example from studies or internships where you maintained accuracy.

3. 15

   Where do you see yourself in three years in pharmacovigilance?

   Show a realistic path: from analyst to senior analyst or subject matter expert in areas like signal detection or aggregate reporting. Mention continuous learning of regulations and tools.

4. 16

   Are you comfortable working in shifts or with global teams across time zones?

   Answer honestly and positively. Mention flexibility, communication skills, and experience with virtual collaboration if any. Avoid saying yes if you cannot commit.